Localized Human Epidermal Growth Factor Receptor (HER2)-Negative Breast Carcinoma
1 clinical trials · Condition
◉ Watch Localized Human Epidermal Growth Factor Receptor (HER2)-Negative Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial (NCT07191717) | Jonsson Comprehensive Cancer Center | 2026-05-18 |
Track Localized Human Epidermal Growth Factor Receptor (HER2)-Negative Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.